DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)

DongKook Pharmaceutical Revenue

DongKook Pharmaceutical had revenue of 258.90B KRW in the quarter ending June 30, 2026, with 10.90% growth. This brings the company's revenue in the last twelve months to 979.60B, up 12.73% year-over-year. In the year 2025, DongKook Pharmaceutical had annual revenue of 926.88B with 14.12% growth.

• Revenue (ttm): 979.60B
• Revenue Growth: +12.73%
• P/S Ratio: 0.91
• Revenue / Employee: 762.33M
• Employees: 1,285
• Market Cap: 890.49B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	926.88B	114.72B	14.12%
Dec 31, 2024	812.17B	81.17B	11.10%
Dec 31, 2023	730.99B	69.35B	10.48%
Dec 31, 2022	661.65B	67.45B	11.35%
Dec 31, 2021	594.19B	35.09B	6.28%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 6, 2026

Data Sources Report a data error